Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed…
HIMS
Novo Nordisk stock climbs out of hole on FDA chief’s threat to block Hims and Hers pill
Novo Nordisk shares rallied on Friday in what’s still been a painful week as the Food…
Hims & Hers launch of compounded $49 Wegovy pill pummels Novo Nordisk’s shares
Published: Feb. 5, 2026 at 10:56 a.m. ET Hims & Hers Health launched a cheaper, compounded version…
‘Women deserve an apology’: For menopause, hormone therapy is now considered safe — just in time for aging millennials
The FDA no longer requires a safety warning on hormone-replacement therapies, at a time when more…
Novo Nordisk’s Wegovy could soon have a new sales outlet in the U.S.
Telehealth company Hims & Hers says it is in “active discussions” with Novo Nordisk about selling…
Hims & Hers stock nears one-year low amid battle over compounded Wegovy pill
Published: Feb. 6, 2026 at 3:29 p.m. ET Hims & Hers Health’s stock was on track to…